Harvard Bioscience (NASDAQ:HBIO) is scheduled to release its earnings data before the market opens on Wednesday, February 26th. Analysts expect Harvard Bioscience to post earnings of $0.07 per share for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link.
NASDAQ:HBIO opened at $2.60 on Wednesday. Harvard Bioscience has a one year low of $1.51 and a one year high of $4.66. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.31 and a current ratio of 2.41. The stock has a market cap of $97.84 million, a PE ratio of -32.50 and a beta of 1.51. The stock has a 50 day moving average price of $2.99 and a 200 day moving average price of $2.86.
Several research firms recently commented on HBIO. Zacks Investment Research cut Harvard Bioscience from a “buy” rating to a “hold” rating in a report on Wednesday, January 8th. TheStreet cut Harvard Bioscience from a “c-” rating to a “d+” rating in a research note on Monday, February 10th. ValuEngine cut Harvard Bioscience from a “buy” rating to a “hold” rating in a research note on Tuesday, October 22nd. Finally, Benchmark cut Harvard Bioscience to a “buy” rating in a research note on Monday, December 9th. Three analysts have rated the stock with a hold rating and one has given a buy rating to the company. Harvard Bioscience has an average rating of “Hold” and an average price target of $2.50.
Harvard Bioscience Company Profile
Harvard Bioscience, Inc provides scientific instruments, systems, software, and services used in life science basic research, drug discovery, and clinical and environmental testing. The company offers physiology, cell, and molecular instruments, such as traditional syringe pump and peristaltic pump products, as well as a range of instruments and accessories for tissue, organ, and animal based lab research under the Harvard Apparatus, CMA Microdialysis, Panlab, Coulbourn, and Hugo Sachs brands; and spectrophotometers, microplate readers, amino acid analyzers, gel electrophoresis equipment, sample preparation plates and columns, and electroporation and electrofusion instruments under the Biochrom, BioDrop, Hoefer, Scie-plas, QuikPrep, and BTX brands.
Read More: Treasury Bonds
Receive News & Ratings for Harvard Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Harvard Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.